Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

Sanofi's Dupixent Wins NMPA Approval in China for Adolescent and Adult CRSwNP – First Biologic to Cover Both Age Groups in Chronic Rhinosinusitis with Nasal Polyps
CompanyDrug

Sanofi’s Dupixent Wins NMPA Approval in China for Adolescent and Adult CRSwNP – First Biologic to Cover Both Age Groups in Chronic Rhinosinusitis with Nasal Polyps

Sanofi (NASDAQ: SNY) announced that China's National Medical Products Administration (NMPA) has approved a new indication application for dupilumab (trade name: Dupixent), for use in combination with intranasal corticosteroids in…

Bayer's Hyrnuo (Sevabertinib) Wins NMPA Approval in First‑Line HER2‑Mutant NSCLC – Oral TKI Moves Into Treatment‑Naive Patients on 75.3 % ORR from SOHO‑01

Bayer’s Hyrnuo (Sevabertinib) Wins NMPA Approval in First‑Line HER2‑Mutant NSCLC – Oral TKI Moves Into Treatment‑Naive Patients on 75.3 % ORR from SOHO‑01

Boehringer Ingelheim and Sino Biopharmaceutical Forge Strategic Multi‑Project ADC and TCE Option Deal – $358 Million Upfront, Up to $7 Billion in Milestones Across Six Preclinical Cancer Programs

Boehringer Ingelheim and Sino Biopharmaceutical Forge Strategic Multi‑Project ADC and TCE Option Deal – $358 Million Upfront, Up to $7 Billion in Milestones Across Six Preclinical Cancer Programs

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

BeiGene’s Brukinsa Receives Marketing Approval in Brazil

CompanyDrug

Fujian Cosunter Receives Multiple Patents for Cancer and Hepatitis Drugs

CompanyDrug

LianBio Initiates Phase I Study of SHP2 Inhibitor BBP-398 in China

CompanyDrug

NMPA Conditionally Approves Yingli Pharma’s Linperlisib for Lymphoma

CompanyDrug

Ascentage Pharma Gains CDE Approval for Phase I Study of APG-5918

CompanyDrug

Betta Pharmaceuticals’ BPI-D0316 Shows Promise in Phase II/III Lung Cancer Study

CompanyDeals

Cowell Health Partners with AstraZeneca to Enhance Cancer Care at CIIE

CompanyDeals

Adicon Partners with Illumina to Advance Oncology Detection Assay TSO 500

Show More